Literature DB >> 18587006

Functions of the complement components C3 and C5 during sepsis.

Michael A Flierl1, Daniel Rittirsch, Brian A Nadeau, Danielle E Day, Firas S Zetoune, J Vidya Sarma, Markus S Huber-Lang, Peter A Ward.   

Abstract

Activation of the complement system is a key event in the pathogenesis of sepsis. Nevertheless, the exact mechanisms remain inadequately understood. In the current study, we examined the role of complement C3 and C5 in sepsis in wild-type and C3- or C5-deficient mice induced by cecal ligation and puncture. When compared to wild-type mice, C5(-/-) showed identical survival, and C3(-/-) presented significantly reduced survival. Interestingly, this was associated with significant decreases in plasma levels of proinflammatory mediators. Moreover, although septic C3(-/-) animals displayed a 10-fold increase of blood-borne bacteria, C5(-/-) animals exhibited a 400-fold increase in bacteremia when compared to wild-type mice. These effects were linked to the inability of C5(-/-) mice to assemble the terminal membrane attack complex (MAC), as determined by complement hemolytic activity (CH-50). Surprisingly, although negative control C3(-/-) mice failed to generate the MAC, significant increases of MAC formation was found in septic C3(-/-) mice. In conclusion, our data corroborate that hemolytic complement activity is essential for control of bacteremia in septic mice. Thus, during sepsis, blockade of C5a or its receptors (rather than C5) seems a more promising strategy, because C5a-blockade still allows for MAC formation while the adverse effects of C5a are prevented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18587006      PMCID: PMC2537435          DOI: 10.1096/fj.08-110595

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  55 in total

Review 1.  Cytokine therapeutics for the treatment of sepsis: why has nothing worked?

Authors:  Daniel G Remick
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

2.  Complement C5a in the sepsis syndrome--too much of a good thing?

Authors:  Craig Gerard
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

3.  Complement-induced impairment of innate immunity during sepsis.

Authors:  Markus S Huber-Lang; Ellen M Younkin; J Vidya Sarma; Stephanie R McGuire; Kristina T Lu; Ren Feng Guo; Vaishalee A Padgaonkar; John T Curnutte; Richard Erickson; Peter A Ward
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

Review 4.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

5.  C5a receptor and thymocyte apoptosis in sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Ines J Laudes; Katie Keller; Vidya J Sarma; Vaishalee Padgaonkar; Firas S Zetoune; Peter A Ward
Journal:  FASEB J       Date:  2002-04-23       Impact factor: 5.191

6.  Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis.

Authors:  Ines J Laudes; Jeffrey C Chu; Sujata Sikranth; Markus Huber-Lang; Ren-Feng Guo; Niels Riedemann; J Vidya Sarma; Alvin H Schmaier; Peter A Ward
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

7.  Protective effects of anti-C5a peptide antibodies in experimental sepsis.

Authors:  M S Huber-Lang; J V Sarma; S R McGuire; K T Lu; R F Guo; V A Padgaonkar; E M Younkin; I J Laudes; N C Riedemann; J G Younger; P A Ward
Journal:  FASEB J       Date:  2001-01-19       Impact factor: 5.191

8.  Protection of innate immunity by C5aR antagonist in septic mice.

Authors:  Markus S Huber-Lang; Niels C Riedeman; J Vidya Sarma; Ellen M Younkin; Stephanie R McGuire; Ines J Laudes; Kristina T Lu; Ren-Feng Guo; Thomas A Neff; Vaishalee A Padgaonkar; John D Lambris; L Spruce; D Mastellos; Firas S Zetoune; Peter A Ward
Journal:  FASEB J       Date:  2002-10       Impact factor: 5.191

9.  Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation.

Authors:  Tom Eirik Mollnes; Ole-Lars Brekke; Michael Fung; Hilde Fure; Dorte Christiansen; Grethe Bergseth; Vibeke Videm; Knut Tore Lappegård; Jörg Köhl; John D Lambris
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

Review 10.  The enigma of sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Peter A Ward
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

View more
  38 in total

1.  Molecular intercommunication between the complement and coagulation systems.

Authors:  Umme Amara; Michael A Flierl; Daniel Rittirsch; Andreas Klos; Hui Chen; Barbara Acker; Uwe B Brückner; Bo Nilsson; Florian Gebhard; John D Lambris; Markus Huber-Lang
Journal:  J Immunol       Date:  2010-09-24       Impact factor: 5.422

2.  A novel C5a-neutralizing mirror-image (l-)aptamer prevents organ failure and improves survival in experimental sepsis.

Authors:  Kai Hoehlig; Christian Maasch; Nelli Shushakova; Klaus Buchner; Markus Huber-Lang; Werner G Purschke; Axel Vater; Sven Klussmann
Journal:  Mol Ther       Date:  2013-07-26       Impact factor: 11.454

Review 3.  Interactions between coagulation and complement--their role in inflammation.

Authors:  Katerina Oikonomopoulou; Daniel Ricklin; Peter A Ward; John D Lambris
Journal:  Semin Immunopathol       Date:  2011-08-03       Impact factor: 9.623

Review 4.  Harmful molecular mechanisms in sepsis.

Authors:  Daniel Rittirsch; Michael A Flierl; Peter A Ward
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

5.  Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes.

Authors:  Anna Krasnodembskaya; Gianluca Samarani; Yuanlin Song; Hanjing Zhuo; Xiao Su; Jae-Woo Lee; Naveen Gupta; Mario Petrini; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-16       Impact factor: 5.464

Review 6.  Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis.

Authors:  Markus Bosmann; Peter A Ward
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

7.  Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model.

Authors:  Z Shao; T Nishimura; L L K Leung; J Morser
Journal:  J Thromb Haemost       Date:  2015-05-10       Impact factor: 5.824

8.  The effect of human complement C3 protein applied at different times in treatment of polymicrobial sepsis.

Authors:  Yujie Yuan; Jianan Ren; Guosheng Gu; Shougen Cao; Jieshou Li
Journal:  Inflamm Res       Date:  2012-02-16       Impact factor: 4.575

9.  Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis.

Authors:  Ravi Shankar Keshari; Robert Silasi; Narcis Ioan Popescu; Maulin Mukeshchandra Patel; Hala Chaaban; Cristina Lupu; K Mark Coggeshall; Tom Eirik Mollnes; Steven J DeMarco; Florea Lupu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-18       Impact factor: 11.205

10.  Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli.

Authors:  Matthew A Crawford; Yinghua Zhu; Candace S Green; Marie D Burdick; Patrick Sanz; Farhang Alem; Alison D O'Brien; Borna Mehrad; Robert M Strieter; Molly A Hughes
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.